Company profile: Hamilton Thorne
1.1 - Company Overview
Company description
- Provider of advanced laser systems and instruments for in-vitro cell applications in regenerative medicine research and fertility clinic markets. Offerings include ZILOS-tk and XYClone lasers that attach to inverted microscopes and act as robotic micro-surgeons; sperm analyzers and CASA platforms (IVOS II, TOX IVOS II), IVF equipment, and ZANDAIR PCOC3 in-duct air purification.
Products and services
- ZILOS-tk and XYClone Laser Systems: Microscope-integrated lasers that attach to standard inverted microscopes and operate as robotic micro-surgeons for in-vitro cell applications, reducing procedural time in fertility and regenerative medicine
- IVOS II: Laboratory-grade CASA platform for sperm analysis supporting a wide range of animal species, used in research and toxicology assessments across animal reproductive studies
- TOX IVOS II: Animal-model-focused system engineered for toxicology studies that assesses the impact of substances on sperm motility and quality in animal reproductive models
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Hamilton Thorne
Syndesi Therapeutics
HQ: Belgium
Website
- Description: Provider of drug candidates and molecules that uniquely modulate the synaptic vesicle protein SV2A to regulate synaptic transmission, representing a promising approach to treating Alzheimer’s disease and other neurological disorders with cognitive impairment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Syndesi Therapeutics company profile →
BioDot
HQ: United States
Website
- Description: Provider of automated low-volume, non-contact quantitative fluid dispensing systems and lamination, cutting, and assembly expertise. Platforms enable direct dispensing of lines and dots on membranes, papers, microwell plates, slides, and microfluidics, plus web handling and dip coating from roll stock and auto lamination, serving R&D through high-volume manufacturing in industrial, diagnostic, life science, and medical markets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioDot company profile →
Cold Chain Technologies
HQ: United States
Website
- Description: Provider of thermal packaging solutions protecting temperature-sensitive products for pharmaceutical, life sciences, and food services, including insulated parcel and pallet shippers, thermal cargo blankets, single-use systems (CCT Advanced SU48), reusable program management, smart digital solutions, logistics management, thermal packaging design, thermal modeling, temperature profile analysis, and an online solution selector.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cold Chain Technologies company profile →
iSpecimen
HQ: United States
Website
- Description: Provider of an online marketplace connecting researchers to millions of human biospecimens and patients across a global network of providers, streamlining specimen procurement. Offers diagnostic remnant, banked, and prospectively collected samples, including biofluids with associated test and clinical data, tissue with clinical/molecular annotation, stem and immune cells with donor attribute options, and matched sets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full iSpecimen company profile →
Nektar Therapeutics
HQ: United States
Website
- Description: Provider of therapeutics based on an advanced polymer conjugate chemistry platform, including Rezpegaldesleukin (REZPEG/NKTR-358), a regulatory T cell stimulator targeting the IL-2 receptor complex to address immune imbalances in autoimmune and inflammatory diseases; PEG-CSF Protein to modulate inflammation resolution; and a bivalent TNFR antibody that selectively stimulates TNFR2 to enhance T regulatory cell function.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nektar Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Hamilton Thorne
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Hamilton Thorne
2.2 - Growth funds investing in similar companies to Hamilton Thorne
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Hamilton Thorne
4.2 - Public trading comparable groups for Hamilton Thorne
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →